1,4-Diazabicyclo[3.2.1]octane dihydrochloride

Catalog No.: 
ACLQDA189
CAS No.: 
5492-61-5
Molecular Formula: 
C6H14Cl2N2
Molecular Weight: 
185.10
1,4-Diazabicyclo[3.2.1]octane dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$63.00In stockInquiry
250mg95%$109.00In stockInquiry
1g95%$218.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,4-Diazabicyclo[3.2.1]octane dihydrochloride
IUPAC Name(1R)-1,4-diazabicyclo[3.2.1]octane dihydrochloride
MDL No.MFCD27976570
Molecular FormulaC6H14Cl2N2
Molecular Weight185.10
SMILES[H]Cl.[H]Cl.[N@]1(C2)CCNC2CC1
InChI KeyCTBNEKSAJTWOFM-UHFFFAOYSA-N
Synonym1,4-diazabicyclo[3.2.1]octane dihydrochloride | 5492-61-5 | (1R)-1,4-Diazabicyclo[3.2.1]octane dihydrochloride | 1,4-diazabicyclo[3.2.1]octane 2hcl | 1,4-diazabicyclo[3.2.1]octane;dihydrochloride | MFCD27976570 | 1,4-Diazabicyclo[3.2.1]octane diHCl | MFCD23704632 | (1R,5
CAS No.5492-61-5
PubChem CID12374078

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACLQDA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLQDA189 route product structure diagram
    ACLQDA1895492-61-5In Stock
Inquiry

2. ACLQDA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLQDA189 route product structure diagram
    ACLQDA1895492-61-5In Stock
Inquiry

3. ACLQDA189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLQDA189 route product structure diagram
    ACLQDA1895492-61-5In Stock
Inquiry

Comments (0)